CPRX
Catalyst Pharmaceuticals Inc
$31.45
0.01 (0.05%) Today
— up— down
Market Cap
$3.85B+45.0%
Revenue (TTM)
$575.86M+11.7%
Net Income (TTM)
$212.97M+10.7%
EPS (TTM)
1.74+10.7%
Shares Out
122.42M
122.42MP/E Ratio
17.38
17.38Forward P/E
14.33
14.33Open
$31.43
$31.43Previous Close
$31.46
$31.46Day Range
$31.43 – $31.46
$31.43 – $31.4652-Week Range
$19.05 – $32.56
$19.05 – $32.56Beta
0.76
0.76Volume
66.14K
66.14KAvg Volume
1.95M
1.95MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout CPRX
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Firdapse commercially launched in January 2019.
